Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

687
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
687
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Molecular Models02:00

Molecular Models

38.1K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Enhancing the Predictive Power of Macrocyclic Drug Permeability by Knowledge Distillation from Analogous Pretraining Data.

Journal of medicinal chemistry·2025
Same author

Designing fluorescent estrogen mimetic 7-hydroxycoumarin probe substrates for human sulfotransferase enzymes.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025
Same author

Atomistic simulations reveal impacts of missense mutations on the structure and function of SynGAP1.

Briefings in bioinformatics·2024
Same author

Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators.

Molecules (Basel, Switzerland)·2023
Same author

Ligand-Enhanced Negative Images Optimized for Docking Rescoring.

International journal of molecular sciences·2022
Same author

Rational design, optimization, and biological evaluation of novel α-Phosphonopropionic acids as covalent inhibitors of Rab geranylgeranyl transferase.

Journal of enzyme inhibition and medicinal chemistry·2022

相关实验视频

Updated: Jun 17, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

构建以形状为重点的药模型,以进行有效的对接选.

Paola Moyano-Gómez1,2, Jukka V Lehtonen3,4, Olli T Pentikäinen1,2,5

  • 1MedChem.fi, Institute of Biomedicine, Integrative Physiology and Pharmacology, University of Turku, 20014, Turku, Finland.

Journal of cheminformatics
|August 9, 2024
PubMed
概括

我们开发了O-LAP,这是一种用于分子对接的新算法,通过建模蛋白质结合腔体来提高准确性. 这种以形状为重点的药方法提高了药物发现中的联体鉴定.

关键词:
基准测试 (benchmarking) 是一种比较的方法.基于距离的图表聚类.停靠对接 复制 复制 复制药物发现 药物发现灵活的合物分子对接.形状的相似性 形状的相似性以形状为重点的药科孔模拟.虚拟选是一个虚拟的选.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

498
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

相关实验视频

Last Updated: Jun 17, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

498
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

科学领域:

  • 计算化学计算化学
  • 结构生物学 结构生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 通过将连接体姿势与反向蛋白质结合腔相比较,可以提高分子对接性能.
  • 形状相似性和富化驱动的优化是提高对接精度的关键.
  • 现有的方法可能无法完全捕捉结合点的复杂形状和静电特性.

研究的目的:

  • 介绍O-LAP,一个新的以形状为中心的药模拟算法.
  • 通过对重叠的原子内容的图形集群生成新的空洞填充模型.
  • 评估O-LAP在改善分子对接丰富和恢复方面的有效性.

主要方法:

  • 开发了O-LAP,这是一个基于C++/Qt5的算法,使用双向距离图集群.
  • 使用灵活对接的活体配体的顶级姿势生成空腔填充模型.
  • 基准测试的O-LAP与五个药物目标,使用随机培训/测试划分和评估丰富.

主要成果:

  • 通过O-LAP建模,在重定位任务中显著改善了默认对接丰富性.
  • 由O-LAP生成的集群模型在刚性对接场景中表现出有效性.
  • 该算法成功地将形状和静电电位与样本中的分子对接姿势进行了比较.

结论:

  • O-LAP提供了一种新的方法,用于用于药物发现的以形状为重点的药模拟.
  • 该算法通过改进的结合点建模有效地提高了分子对接性能.
  • 通过全面的测试验证,O-LAP在对接复合和刚性对接方面都确保了高丰富度.